Validation of the graded prognostic assessment for lung cancer with brain metastases using molecular...
Validation of the graded prognostic assessment for lung cancer with brain metastases using molecular markers (lung-molGPA)
About this item
Full title
Author / Creator
Publisher
England: BioMed Central Ltd
Journal title
Language
English
Formats
Publication information
Publisher
England: BioMed Central Ltd
Subjects
More information
Scope and Contents
Contents
Many patients with brain metastases from non-small cell lung cancer have limited survival, while others survive for several years, depending on patterns of spread, EGFR and ALK alterations, among others. The purpose of this study was to validate a new prognostic model (Lung-molGPA) originally derived from a North American database.
This retrospe...
Alternative Titles
Full title
Validation of the graded prognostic assessment for lung cancer with brain metastases using molecular markers (lung-molGPA)
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_e088ecf23b534b36b51dff9b9c0f4309
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_e088ecf23b534b36b51dff9b9c0f4309
Other Identifiers
ISSN
1748-717X
E-ISSN
1748-717X
DOI
10.1186/s13014-017-0844-6
